Clinical efficacy of novel combinations of older beta-lactam and beta-lactamase inhibitors: Where are the evidences?

Veeraraghavan, Balaji; Bakthavatchalam, Yamuna Devi; Kandasamy, Subramani; Iyadurai, Ramya

Clinical efficacy of novel combinations of older beta-lactam and beta-lactamase inhibitors: Where are the evidences?

Veeraraghavan, Balaji; Bakthavatchalam, Yamuna Devi; Kandasamy, Subramani; Iyadurai, Ramya.

Afiliação

Veeraraghavan B; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Bakthavatchalam YD; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Kandasamy S; The Critical Care Division, Christian Medical College, Vellore, India.
Iyadurai R; Department of Medicine, Christian Medical College, Vellore, India. Electronic address: iramya@cmcvellore.ac.in.

Indian J Med Microbiol ; 40(2): 179-181, 2022.

Article em En | MEDLINE | ID: mdl-34972570

Assuntos

Sulbactam; Inibidores de beta-Lactamases; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Humanos; Testes de Sensibilidade Microbiana; Sulbactam/uso terapêutico; Resultado do Tratamento; Inibidores de beta-Lactamases/farmacologia; Inibidores de beta-Lactamases/uso terapêutico; beta-Lactamas/farmacologia

Palavras-chave

CSE 1034; Carbapenemases; ESBL; beta lactam/beta-lactamase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulbactam / Inibidores de beta-Lactamases Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulbactam / Inibidores de beta-Lactamases Idioma: En Ano de publicação: 2022 Tipo de documento: Article